Visa Inc. (V) is scheduled to report earnings results for the fourth quarter of 2018 on Wednesday, October 24 after market close. Analysts expect the company to deliver revenues of $5.42 billion, reflecting a year-over-year increase of 11.6%. Earnings are expected to increase 33% to $1.20 per share.
Visa has consistently topped market expectations over the past four quarters and is on track to continue this trend in the fourth quarter as well. The main driver of the fourth quarter results is expected to be revenue growth. Growth in key business metrics such as payments and cross-border volumes as well as processed transactions will benefit revenues.
Higher economic growth, increased consumer spending and growth in digital payments in several countries are likely to drive increases in payments volume and processed transactions. The demonetization effort in India, which led to an increased shift towards digital transactions in the country, is one example of a growth driver for companies like Visa.
Visa is likely to see an increase in expenses in the fourth quarter due to its continued investments in its products, solutions and technology.
In the third quarter, Visa reported a 39% increase in EPS to $1.20 along with a 15% growth in revenues to $5.2 billion. The company also recorded revenue increases across all its segments along with growth in payments transactions, processed transactions and cross-border volume. For the full year of 2018, Visa has guided for net revenues to grow in the low double-digits.
Last week, Visa’s rival American Express (AXP) reported third quarter results, which topped market estimates. Another competitor Mastercard (MA) is set to report its third quarter results on Tuesday, October 30.
Visa’s shares have climbed 22% thus far this year but looking at the past one month, the stock has dropped 7%. If the company meets expectations, the stock is likely to see a lift.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Comments
Comments are closed.